saddl3 analyzes public drug-development evidence through indication rankings and target landscapes.

Indication summaries make program comparisons accessible. Target landscapes examine mechanisms, clinical evidence, and development prospects in greater detail.

The name stands for structured analysis of drug development literature. The 3 nods to Phase 3, where many drug programs have to prove themselves at pivotal scale before approval.